Urothelial Carcinoma

Urothelial Carcinoma is the indication for 2 drugs in DrugBank. It is covered by 5 curated, structured indications.

Also known as: urothelial cell carcinoma · Carcinoma, Urothelial · urothelial carcinoma (UC)
Classified under: Neoplasms
Urogenital Diseases
Indicated drugs: Hyaluronidase (human recombinant)
Nivolumab

Resolves to

Vocabularies

SNOMED CT189576006MedDRA10007477UMLSC0007138

What you can answer from here — as of October 22, 2026

2Indicated drugsWith each drug's targets and mechanism

Listed above

5Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

438Clinical trialsPhase, status and sponsor resolved per trial

1Drug reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Urothelial Carcinoma share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.